CC chemokine receptor 5 polymorphism in Italian patients with Beḩet's disease

Rheumatology (United Kingdom)

Volumn 51, Issue 12, 2012, Pages 2141-2145

  Atzeni, Fabiola ^a,b   Boiardi, Luigi ^c   Casali, Bruno ^c   Farnetti, Enrico ^c   Nicoli, Davide ^c   Sarzi puttini, Piercarlo ^a   Pipitone, Nicolò ^c   Olivieri, Ignazio ^d   Cantini, Fabrizio ^e   Salvi, Fabrizio ^f   La corte, Renato ^g   Triolo, Giovanni ^h   Filippini, Davide ⁱ   Paolazzi, Giuseppe ^j   Salvarani, Carlo ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d SAN CARLO HOSPITAL   (Italy)

^e MISERICORDIA E DOLCE HOSPITAL   (Italy)

^f BELLARIA HOSPITAL   (Italy)

^g UNIVERSITY OF FERRARA   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

ⁱ OSPEDALE NIGUARDA CA GRANDA   (Italy)

^j SANTA CHIARA HOSPITAL   (Italy)

more..

Author keywords

Be et's disease; CC chemokine receptor 5 32 olymorphism; Chemokines; Disease manifestations

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA B51 ANTIGEN;

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; FOLLOW UP; GENDER; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTYPING;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HLA-B ANTIGENS; HOMOZYGOTE; HUMANS; ITALY; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CCR5;

EID: 84870355384     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes238     Document Type: Article

References (20)

1. Yazici Y, Yurdakul S, Yazici H. Behcet's syndrome. Curr Rheumatol Rep 2010;12:429-35.
2. Seyahi E, Yurdakul S. Behçet's syndrome and thrombosis. Mediterr J Hematol Infect Dis 2011;3:e2011026.
3. Kapsimali VD, Kanakis MA, Vaiopoulos GA, Kaklamanis PG. Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations. Clin Rheumatol 2010;29:1211-6.
4. Houman H, Hamzaoui A, Ben Ghorbal I et al. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations. J Autoimmun 2004;23:267-73.
5. Leng RX, Chen GM, Pan HF, Ye DQ. The role of IL-23/ IL-17 axis in the etiopathogenesis of Behçet's disease. Clin Rheumatol 2010;29:1209.
6. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-21.
7. Prahalad S. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 2006;7:264-8.
8. Petrek M, Drabek J, Kolek V et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;162:1000-3.
9. Yang X, Ahmad T, Gogus F et al. Analysis of the CC chemokine receptor 5 (CCR5) delta32 polymorphism in Behçet's disease. Eur J Immunogenet 2004;31:11-4.
10. Mojtahedi Z, Ahmadi SB, Razmkhah M et al. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behçet's disease is dependent on gender in Iranian patients. Clin Exp Rheumatol 2006;24:S91-4.
11. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335: 1078-80.
12. Yang B, Houlberg K, Millward A, Demaine A. Polymorphisms of chemokine and chemokine receptors in type 1 diabetes mellitus and its complications. Cytokine 2004;26:114-21.
13. Schildkraut JM. Examining complex genetic interactions. In: Haines JL, Pericak-Vance MA, eds. Approach to gene mapping in complex human diseases. New York, NY: Wiley-Liss, 1998:379-410.
14. Petrek M, Cermáková Z, Hutyrová B et al. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2002;20:701-3.
15. Boiardi L, Vaglio A, Nicoli D et al. CC chemokine 5 receptor polymorphism in chronic periaortitis. Rheumatology 2011;50:1025-32.
16. Zhou Y, Huang D, Farver C, Hoffman GS. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J Rheumatol 2003;30:1541-7.
17. Turner JE, Paust HJ, Steinmetz OM et al. CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol 2008;181:6546-56.
18. Bao L, Zhu Y, Zhu J, Lindgren JU. Decreased IgG production but increased MIP-1beta expression in collagen-induced arthritis in C-C chemokine receptor 5-deficient mice. Cytokine 2005;31:64-71.
19. Takeuchi A, Usui Y, Takeuchi M et al. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Invest Ophthalmol Vis Sci 2005;46:3753-60.
20. Paxton WA, Kang S. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol 1998;10:187-94.